About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Convalescent Plasma in the Treatment of COVID 19 | Clinical Trials | Clareo Health

COMPLETEDPhase 2

Convalescent Plasma in the Treatment of COVID 19

NCT04343261•Trinity Health Of New England

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)COVIDCoronavirus

Interventions

Convalescent Plasma

Locations

1

United States

Locations (1)

Trinity Health Of New England

Hartford, Connecticut, United States

Key Dates

Start Date

April 10, 2020

Primary Completion Date

July 23, 2020

Completion Date

August 13, 2020

Last Updated

September 24, 2020

Related Studies

RECRUITINGPhase 3

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

NCT06631287

Long COVIDSars-CoV-2 Infection+2 more

RECRUITINGPhase 1/2

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

NCT04565665

COVID-19 InfectionCOVID-19-Associated Acute Respiratory Distress Syndrome+3 more

RECRUITINGPhase 2

Sonlicromanol in Post-COVID

NCT07298005

Post COVID Condition

Immune-mediated Pathogenic Mechanisms of Neuro-PASC in Veterans

NCT06932237

Neuro-PASCLong COVID

Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)

NCT04978571

Post-Concussion SyndromeCOVID Long-Haul+1 more

RECRUITINGPhase 2/3

Taurine Supplementation in Long COVID

NCT06721949

View all related studies

Sponsors

Lead Sponsor

Trinity Health Of New England

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 24, 2020Data synced to Clareo: April 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions